Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Clinical value of pathologic examination of non-neoplastic kidney in patients with upper urinary tract malignancies.

Wee JW, Kang HR, Kwon SH, Jeon JS, Han DC, Jin SY, Yang WJ, Noh H.

Korean J Intern Med. 2016 Jul;31(4):739-49. doi: 10.3904/kjim.2015.392.

2.

Atypical anti-glomerular basement membrane disease.

Troxell ML, Houghton DC.

Clin Kidney J. 2016 Apr;9(2):211-21. doi: 10.1093/ckj/sfv140.

3.

The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss RH; American Society of Nephrology Onco-Nephrology Forum..

J Am Soc Nephrol. 2016 Aug;27(8):2227-37. doi: 10.1681/ASN.2015121335.

PMID:
26961346
4.

Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function.

Bazzi WM, Chen LY, Cordon BH, Mashni J, Sjoberg DD, Bernstein M, Russo P.

Int Urol Nephrol. 2015 Sep;47(9):1499-502. doi: 10.1007/s11255-015-1066-1.

5.

Risk of chronic kidney disease after nephrectomy for renal cell carcinoma.

Choi SK, Song C.

Korean J Urol. 2014 Oct;55(10):636-42. doi: 10.4111/kju.2014.55.10.636. Review.

6.

Nephron-sparing surgery.

Maroni P, Moss J.

Semin Intervent Radiol. 2014 Mar;31(1):104-6. doi: 10.1055/s-0033-1363851. Review. No abstract available.

7.

Renal histologic parameters influencing postoperative renal function in renal cell carcinoma patients.

Koh MJ, Lim BJ, Choi KH, Kim YH, Jeong HJ.

Korean J Pathol. 2013 Dec;47(6):557-62. doi: 10.4132/KoreanJPathol.2013.47.6.557.

8.

Diabetes and risk of cancer.

Habib SL, Rojna M.

ISRN Oncol. 2013;2013:583786. doi: 10.1155/2013/583786.

9.

End stage and chronic kidney disease: associations with renal cancer.

Russo P.

Front Oncol. 2012 Apr 2;2:28. doi: 10.3389/fonc.2012.00028.

10.

Advancements in laparoscopic partial nephrectomy: expanding the feasibility of nephron-sparing.

Pietzak EJ, Guzzo TJ.

Adv Urol. 2012;2012:148952. doi: 10.1155/2012/148952.

11.

Recent developments in kidney cancer.

Leveridge MJ, Jewett MA.

Can Urol Assoc J. 2011 Jun;5(3):195-203. doi: 10.5489/cuaj.10148.

12.

Residual renal function after partial or radical nephrectomy for renal cell carcinoma.

Chapman D, Moore R, Klarenbach S, Braam B.

Can Urol Assoc J. 2010 Oct;4(5):337-43.

13.

Role of open nephron sparing surgery in the era of minimal invasive surgery.

Gupta G, Grover S, Kumar S, Kekre NS.

Indian J Urol. 2009 Oct-Dec;25(4):508-15. doi: 10.4103/0970-1591.57930.

14.

The contemporary role of surgery in kidney cancer.

Lattouf JB, Trinh QD, Saad F.

Curr Oncol. 2009 May;16 Suppl 1:S8-S15.

15.

Kidney pathological changes in metabolic syndrome: a cross-sectional study.

Alexander MP, Patel TV, Farag YM, Florez A, Rennke HG, Singh AK.

Am J Kidney Dis. 2009 May;53(5):751-9. doi: 10.1053/j.ajkd.2009.01.255.

Items per page

Supplemental Content

Support Center